Literature DB >> 21697700

Distinction of melanoma in situ from solar lentigo on sun-damaged skin using morphometrics and MITF immunohistochemistry.

Will H Black1, Sumeet K Thareja, Brett P Blake, Ren Chen, Basil S Cherpelis, Lewis Frank Glass.   

Abstract

Distinction between melanoma in situ (MIS) and solar lentigo (SL) on chronically sun-damaged skin (CSDS) by hematoxylin and eosin (H&E) criteria alone can be difficult and in frozen section (FS) material, may be virtually impossible without immunohistochemistry (IHC). In this study, we used microphthalmia-associated transcription factor (MITF) IHC-directed image analysis to compare melanocyte nuclear morphometrics of MIS, SL, and sections of sun-damaged skin from redundant tissue acquired during Mohs micrographic surgery. The mean nuclear diameter and melanocytic density figures for MIS were greater than those for SL and CSDS by both independent t-test and analysis of variance statistics. No significant differences in these parameters were found between SL and sun-damaged skin. Cutoff values that favored MIS over SL included melanocyte density ≥10 nuclei per 200 μm, nuclear diameter ≥9 μm, and a product of density and diameter of 80 or more, as each of these values was associated with 100% specificity of MIS diagnosis. Our results suggest that image analysis of melanocytes labeled with MITF IHC can be used to produce morphometric data that distinguish MIS from SL and CSDS. The study was conducted using permanent sections, but previous studies with FSs indicate that the findings would apply to FSs as well. Quantitative assessment of melanocytic parameters using image analysis will likely become increasingly important as an adjunct to conventional histopathology for the diagnosis and surgical management of MIS on sun-damaged skin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697700     DOI: 10.1097/DAD.0b013e3182093b13

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  7 in total

Review 1.  Lentigo maligna and lentigo maligna melanoma: contemporary issues in diagnosis and management.

Authors:  Karen L Connolly; Kishwer S Nehal; Klaus J Busam
Journal:  Melanoma Manag       Date:  2015-05-18

2.  Histopathologic and Immunohistochemical Correlates of Confocal Descriptors in Pigmented Facial Macules on Photodamaged Skin.

Authors:  Ignacio Gómez-Martín; Sara Moreno; Evelyn Andrades-López; Inma Hernández-Muñoz; Fernando Gallardo; Carlos Barranco; Ramon M Pujol; Sonia Segura
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

3.  Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.

Authors:  Cynthia M Magro; Sung-Eun Yang; Jonathan H Zippin; Artur Zembowicz
Journal:  Arch Pathol Lab Med       Date:  2012-12       Impact factor: 5.534

Review 4.  Emerging clinical applications of selected biomarkers in melanoma.

Authors:  Michael T Tetzlaff; Carlos A Torres-Cabala; Penvadee Pattanaprichakul; Ronald P Rapini; Victor G Prieto; Jonathan L Curry
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-01-30

Review 5.  Current perspectives on Mohs micrographic surgery for melanoma.

Authors:  Derek Beaulieu; Ramin Fathi; Divya Srivastava; Rajiv I Nijhawan
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-06-20

Review 6.  Diagnosis and Management of Lentigo Maligna: Clinical Presentation and Comprehensive Review.

Authors:  Piyu Parth Naik
Journal:  J Skin Cancer       Date:  2021-07-24

7.  Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions.

Authors:  Sabrina E Dass; Taryn Huizenga; Mehdi Farshchian; Darius R Mehregan
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.